PMA vs ENVB Comparison

Ming Shing Group Holdings Ltd is a holding company engaged through its subsidiaries in wet trades works, including plastering, tile laying, brick laying, floor screeding and marble works. To a much lesser extent, it provides small-scale fitting out services, such as renovation works, and engages in trading of wines and spirits. Through its subsidiaries, it is mainly engaged in private sector projects in Hong Kong, involving private residential and commercial developments, while public sector projects mainly involve public residential developments, infrastructure and public facilities developments. The Company operates through two segments: Provision of Wet Trades Works and Trading of Wines and Spirits, with Trading of Wines and Spirits generating the maximum revenue.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.